Brief: Microba Life Sciences Secures A$14.5 Million To Drive Clinical Adoption
23/06/2025 08:28
June 23 (Reuters) - Microba Life Sciences Ltd MAP.AX: MICROBA SECURES A$14.5 MILLION TO DRIVE CLINICAL ADOPTION EXPECTED FY25 REVENUE RANGE NARROWED TO A$15.4 - A$16 MILLION Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million